Logo image of 1BAYN.MI

BAYER AG-REG (1BAYN.MI) Stock Fundamental Analysis

BIT:1BAYN - Euronext Milan - DE000BAY0017 - Common Stock - Currency: EUR

27.275  -0.23 (-0.82%)

Fundamental Rating

3

Taking everything into account, 1BAYN scores 3 out of 10 in our fundamental rating. 1BAYN was compared to 50 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of 1BAYN have multiple concerns. 1BAYN has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

1BAYN had positive earnings in the past year.
In the past year 1BAYN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: 1BAYN reported negative net income in multiple years.
In the past 5 years 1BAYN always reported a positive cash flow from operatings.
1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCF1BAYN.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

1.2 Ratios

1BAYN has a worse Return On Assets (-2.98%) than 68.00% of its industry peers.
With a Return On Equity value of -10.03%, 1BAYN is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -2.98%
ROE -10.03%
ROIC N/A
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
1BAYN.MI Yearly ROA, ROE, ROIC1BAYN.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

In the last couple of years the Operating Margin of 1BAYN has declined.
1BAYN's Gross Margin of 53.99% is on the low side compared to the rest of the industry. 1BAYN is outperformed by 68.00% of its industry peers.
In the last couple of years the Gross Margin of 1BAYN has declined.
The Profit Margin and Operating Margin are not available for 1BAYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.99%
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
1BAYN.MI Yearly Profit, Operating, Gross Margins1BAYN.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

1BAYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for 1BAYN remains at a similar level compared to 1 year ago.
1BAYN has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1BAYN has an improved debt to assets ratio.
1BAYN.MI Yearly Shares Outstanding1BAYN.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
1BAYN.MI Yearly Total Debt VS Total Assets1BAYN.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that 1BAYN is in the distress zone and has some risk of bankruptcy.
1BAYN has a worse Altman-Z score (0.84) than 72.00% of its industry peers.
The Debt to FCF ratio of 1BAYN is 6.81, which is on the high side as it means it would take 1BAYN, 6.81 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of 1BAYN (6.81) is comparable to the rest of the industry.
1BAYN has a Debt/Equity ratio of 1.08. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of 1BAYN (1.08) is worse than 64.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.81
Altman-Z 0.84
ROIC/WACCN/A
WACC6.41%
1BAYN.MI Yearly LT Debt VS Equity VS FCF1BAYN.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

2.3 Liquidity

A Current Ratio of 1.25 indicates that 1BAYN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.25, 1BAYN is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
1BAYN has a Quick Ratio of 1.25. This is a bad value and indicates that 1BAYN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.79, 1BAYN is doing worse than 64.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.25
Quick Ratio 0.79
1BAYN.MI Yearly Current Assets VS Current Liabilites1BAYN.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for 1BAYN have decreased strongly by -24.72% in the last year.
1BAYN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.27% yearly.
Looking at the last year, 1BAYN shows a decrease in Revenue. The Revenue has decreased by -0.92% in the last year.
1BAYN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.37% yearly.
EPS 1Y (TTM)-24.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-11.7%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-0.2%

3.2 Future

1BAYN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.07% yearly.
The Revenue is expected to grow by 1.07% on average over the next years.
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y2.07%
Revenue Next Year-0.13%
Revenue Next 2Y0.7%
Revenue Next 3Y1.06%
Revenue Next 5Y1.07%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1BAYN.MI Yearly Revenue VS Estimates1BAYN.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B 50B
1BAYN.MI Yearly EPS VS Estimates1BAYN.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

More info and screens

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.78, the valuation of 1BAYN can be described as very cheap.
96.00% of the companies in the same industry are more expensive than 1BAYN, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of 1BAYN to the average of the S&P500 Index (27.51), we can say 1BAYN is valued rather cheaply.
The Price/Forward Earnings ratio is 5.53, which indicates a rather cheap valuation of 1BAYN.
1BAYN's Price/Forward Earnings ratio is rather cheap when compared to the industry. 1BAYN is cheaper than 98.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 35.58, 1BAYN is valued rather cheaply.
Industry RankSector Rank
PE 5.78
Fwd PE 5.53
1BAYN.MI Price Earnings VS Forward Price Earnings1BAYN.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

78.00% of the companies in the same industry are more expensive than 1BAYN, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, 1BAYN is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.64
EV/EBITDA 7.42
1BAYN.MI Per share data1BAYN.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.15%
EPS Next 3Y1.51%

More info and screens

0

5. Dividend

5.1 Amount

With a yearly dividend of 0.40%, 1BAYN is not a good candidate for dividend investing.
1BAYN's Dividend Yield is slightly below the industry average, which is at 3.00.
With a Dividend Yield of 0.40, 1BAYN pays less dividend than the S&P500 average, which is at 2.35.
Industry RankSector Rank
Dividend Yield 0.4%

5.2 History

The dividend of 1BAYN decreases each year by -45.34%.
Dividend Growth(5Y)-45.34%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of 1BAYN are negative and hence is the payout ratio. 1BAYN will probably not be able to sustain this dividend level.
DP-4.03%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
1BAYN.MI Yearly Income VS Free CF VS Dividend1BAYN.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B -10B

More info and screens

BAYER AG-REG

BIT:1BAYN (7/14/2025, 7:00:00 PM)

27.275

-0.23 (-0.82%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)05-13 2025-05-13/bmo
Earnings (Next)08-06 2025-08-06
Inst Owners41.07%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap26.80B
Analysts71.72
Price Target28.79 (5.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.4%
Yearly Dividend0.13
Dividend Growth(5Y)-45.34%
DP-4.03%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.63%
Min EPS beat(2)1.86%
Max EPS beat(2)3.41%
EPS beat(4)3
Avg EPS beat(4)-1.9%
Min EPS beat(4)-17.26%
Max EPS beat(4)4.42%
EPS beat(8)5
Avg EPS beat(8)-2.92%
EPS beat(12)8
Avg EPS beat(12)-2.14%
EPS beat(16)12
Avg EPS beat(16)1.92%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-0.98%
Max Revenue beat(2)1.79%
Revenue beat(4)2
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-3.42%
Max Revenue beat(4)1.79%
Revenue beat(8)2
Avg Revenue beat(8)-2.63%
Revenue beat(12)4
Avg Revenue beat(12)-2.01%
Revenue beat(16)8
Avg Revenue beat(16)-0.66%
PT rev (1m)2.57%
PT rev (3m)4.28%
EPS NQ rev (1m)-1.12%
EPS NQ rev (3m)-11.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.27%
Revenue NQ rev (1m)1.24%
Revenue NQ rev (3m)-0.84%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.25%
Valuation
Industry RankSector Rank
PE 5.78
Fwd PE 5.53
P/S 0.58
P/FCF 4.64
P/OCF 3.15
P/B 0.83
P/tB N/A
EV/EBITDA 7.42
EPS(TTM)4.72
EY17.31%
EPS(NY)4.93
Fwd EY18.09%
FCF(TTM)5.88
FCFY21.57%
OCF(TTM)8.65
OCFY31.73%
SpS47.41
BVpS33.03
TBVpS-18.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.98%
ROE -10.03%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.99%
FCFM 12.41%
ROA(3y)-0.5%
ROA(5y)-1.93%
ROE(3y)-2.08%
ROE(5y)-7.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)7.82%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-18.1%
OM growth 5Y-4.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.21%
GM growth 5Y-1.81%
F-Score3
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.08
Debt/FCF 6.81
Debt/EBITDA 4.37
Cap/Depr 30.76%
Cap/Sales 5.84%
Interest Coverage N/A
Cash Conversion 106.2%
Profit Quality N/A
Current Ratio 1.25
Quick Ratio 0.79
Altman-Z 0.84
F-Score3
WACC6.41%
ROIC/WACCN/A
Cap/Depr(3y)34.81%
Cap/Depr(5y)41.62%
Cap/Sales(3y)5.85%
Cap/Sales(5y)5.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.72%
EPS 3Y-8.12%
EPS 5Y-5.27%
EPS Q2Q%-11.7%
EPS Next Y-8.65%
EPS Next 2Y-1.15%
EPS Next 3Y1.51%
EPS Next 5Y2.07%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y1.87%
Revenue growth 5Y1.37%
Sales Q2Q%-0.2%
Revenue Next Year-0.13%
Revenue Next 2Y0.7%
Revenue Next 3Y1.06%
Revenue Next 5Y1.07%
EBIT growth 1Y-214.77%
EBIT growth 3Y-16.56%
EBIT growth 5Y-3.03%
EBIT Next Year63.3%
EBIT Next 3Y21.17%
EBIT Next 5Y10.6%
FCF growth 1Y380.55%
FCF growth 3Y22.16%
FCF growth 5Y-3.69%
OCF growth 1Y99.13%
OCF growth 3Y12.83%
OCF growth 5Y-2.09%